The aim of this study was to investigate whether serum IGFBP-1 in its non-phosphorylated and phosphorylated forms as well as MMP-8 would associate with serum markers of low-grade inflammation and the metabolic profile in pregnant women at high risk for metabolic disorders, i.e. in overweight and obese women. This evidence concerns the gene MMP8 and Other metabolic disease.